5th Patient Adherence and Advocacy Summit

Time:February 27-28, 2014

Venue:Hyatt at The Bellevue, Philadelphia, PA

Organizer:ExL Pharma

  • Share on Facebook
  • Tweet
  • Post to Tumblr
  • Pin it
  • Add to Pocket
  • Submit to Reddit
  • Share on LinkedIn
  • Publish on WordPress
  • Save to Pinboard
  • Send email

 

  5th Patient Adherence And Advocacy Summit
 
  Non-adherence results in massive costs for the Health System and and an enormous loss of potential revenue for the pharmaceutical industry. Interventions to improve medication adherence should be top priority for pharmaceutical companies and will prove beneficial to all stakeholders. Increasing adherence rates by only 10 % would translate into billions of dollars of pharmaceutical revenue opportunity in the US alone.
 
  This summit brings together a variety of different key stakeholders to discuss how they can partner with the pharmaceutical industry to improve patient adherence. Academia shares the latest findings in adherence research, technology providers give an update on innovative tools to engage patients and assist them, advocacy groups outline patient needs and share best practices on how to raise awareness and the industry analyzes how successful collaborations, adherence programs and effective marketing have resulted in behavioral change.
 
  TOP FIVE REASONS TO ATTEND
 
  Don’t miss your chance to network and discuss important topics with different stakeholders such as HCPs, caregivers, policy makers, academia, advocacy groups and the pharmaceutical industry to foster meaningful relationships
 
  Understand the patients needs and learn how a patient-centric approach can reduce drop off rates
 
  Learn about the latest findings in research
 
  Discover new and innovative technologies for consumer engagement to improve adherence
 
  Understand the changing landscape for Managed Care

Contact:sponsor

Tel:(212) 400-6240

Fax:(888) 221-6750

E-mail:info@exlpharma.com

Website:http://www.exlpharma.com/Adherence

PharmaSources Customer Service